Literature DB >> 10386186

Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression.

P R Gard1, A Mandy, M A Sutcliffe.   

Abstract

BACKGROUND: Angiotensin-converting enzyme inhibitors are reportedly effective in the treatment of depression; furthermore, antidepressants decrease angiotensin function. It appears therefore that reduced angiotensin function may be important in the treatment of depression. The aims of this study were to elucidate the actions of antidepressants on angiotensin receptors; to investigate the antidepressant potential of an angiotensin antagonist; and to study angiotensin receptors in depressed puerperal women.
METHODS: The effects of antidepressant drugs on angiotensin receptors and the relationship between mood and platelet receptors in puerperal women were investigated using radioligand binding. The antidepressant potential of the angiotensin antagonist losartan was assessed using the mouse forced swim test.
RESULTS: Desipramine, but neither fluoxetine nor tranylcypromine, displaced angiotensin from its receptor; however, there was no significant relationship between receptor number and depressed mood. In the forced swim test losartan was shown to possess antidepressant like activity.
CONCLUSIONS: These findings indicate that antidepressants differ in the mechanism by which they reduce angiotensin function, but the link between antidepressants and angiotensin is reiterated by the demonstration that losartan possesses antidepressant like activity. There is, however, no evidence of abnormal angiotensin receptors in women with depressed mood postpartum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386186     DOI: 10.1016/s0006-3223(98)00101-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  17 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 3.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

4.  Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.

Authors:  Jana D Tchekalarova; Natasha Ivanova; Dimitrina Atanasova; Daniela M Pechlivanova; Nikolai Lazarov; Lidia Kortenska; Rumiana Mitreva; Valentin Lozanov; Alexander Stoynev
Journal:  Cell Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.046

5.  AGTR1 gene variation: association with depression and frontotemporal morphology.

Authors:  Warren D Taylor; Sophiya Benjamin; Douglas R McQuoid; Martha E Payne; Ranga R Krishnan; James R MacFall; Allison Ashley-Koch
Journal:  Psychiatry Res       Date:  2012-06-15       Impact factor: 3.222

Review 6.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

Review 7.  Vascular growth factors in neuropsychiatry.

Authors:  Samuel S Newton; Neil M Fournier; Ronald S Duman
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

8.  Cardiovascular drugs and the risk of suicide: a nested case-control study.

Authors:  Torbjörn Callréus; Ulla Agerskov Andersen; Jesper Hallas; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2007-03-20       Impact factor: 2.953

9.  Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial.

Authors:  Ehsan Bahramali; Negar Firouzabadi; Ilnaz Yavarian; Mohammad Reza Hooshangi Shayesteh; Nasrallah Erfani; Ali Alavi Shoushtari; Roja Asadpour
Journal:  Eur J Clin Pharmacol       Date:  2016-06-05       Impact factor: 2.953

Review 10.  Salt craving: the psychobiology of pathogenic sodium intake.

Authors:  Michael J Morris; Elisa S Na; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2008-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.